Aceclofenac + Thiocolchicoside Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 100mg + 4mg
Reference Brands: Various regional brands
Category:
Analgesic
Aceclofenac + Thiocolchicoside combines an anti-inflammatory agent with a muscle relaxant. Aceclofenac reduces prostaglandin synthesis to alleviate pain and inflammation, while thiocolchicoside relaxes muscles. Benefits include rapid relief of musculoskeletal pain, decreased muscle spasms, improved mobility, and enhanced comfort in conditions like strain, sprain, and degenerative joint diseases.
Aceclofenac + Thiocolchicoside Tablet is available in Tablets
and strengths such as 100mg + 4mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Aceclofenac + Thiocolchicoside Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Aceclofenac + Thiocolchicoside Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Aceclofenac + Thiocolchicoside are regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and MDR standards. In the US, approval involves validation, safety assessments, and GMP compliance; however, the combination is mostly used in compounded formulations. In the EU, CE marking certifies conformity with MDR regulations, with the formulation approved for pain and muscle spasm management. These products undergo validation, stability testing, and audits, supported by detailed safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality formulations supporting musculoskeletal therapy worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing